PI(22:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Metabolite details

Identifier

IFCXODPCRNYZJX-LJUYVFDDSA-N

InChI Key

IFCXODPCRNYZJX-LJUYVFDDSA-N

IUPAC name

[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (Z)-docos-11-enoate

Preferred name

PI(22:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

INN name

—

Synonym

—

ChEBI

CHEBI:194569

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates

Observed in differential profiles

• Control_Liver_vs_Treatment_Liver